IL6 and intrahepatic cholangiocarcinoma: No statistically significant differences for these markers were observed between ICC and ECC subtypes (p = 0.677 for GM-CSF; p = 0.119 for IL-6), although a trend was evident for MDSCs (p = 0.055).